Search

Issue
Title
Authors
Modern indications for stem cell transplantation in primary diagnosed pediatric acute lymphoblastic leukemia
Valiev T.T.
The significance of CD20 expression in adult patients with BCR::ABL1-negative acute B-cell lymphoblastic leukemia treated according to RALL-2016 protocol
Aleshina O.A., Kotova E.S., Galtseva I.V., Chabaeva Y.A., Dvirnyk V.N., Parovichnikova E.N.
COVID-19 in patients with acute leukemia: 3 years' experience of pandemic
Chudnova T.S., Misyurina E.N., Baryakh E.A., Tolstykh T.N., Shimanovskaya L.T., Gagloeva D.E., Zhelnova E.I., Makeshova A.B., Yatskov K.V., Zotina E.N., Ivanova D.D., Mingalimov M.A., Kochneva O.L., Grishina E.Y., Polyakov Y.Y., Yakimets V.N.
Lineage switch in relapse of acute leukemia with rearrangement of MLL gene (KMT2A). literature review and case reports
Zerkalenkova E.A., Illarionova O.I., Kazakova A.N., Ponomareva N.I., Baydun L.V., Osipova E.Y., Dubrovina M.E., Popov A.M., Konyukhova T.V., Plyasunova S.A., Myakova N.V., Maschan A.A., Olshanskaya Y.V.
Risk factors of CMV replication after allogeneic hematopoietic stem cell transplantation in children and adolescents
Shiriaev S.N., Stancheva N.V., Morozova Y.V., Barkhatov I.M., Averianova M.Y., Razumova S.V., Goloshchapov O.V., Chukhlovin A.B., Zubarovskaya L.S., Afanasiev B.V.
Ocular involvement in pediatric patients with acute leukemia relapse: points of diagnosis and treatment
Radzhabova G.A., Mashchyts V.D., Naumenko L.V., Valiev T.T.
Clinical and molecular-biologic features of infant acute leukemia
Korkina Y.S., Valiev T.T., Varfolomeeva S.R.
Basic therapeutic approaches to the management of hematology/oncology patients with new coronavirus infection (COVID-19)
Misyurina E.N., Baryakh E.A., Frolova N.F., Kotenko O.N., Mutovina Z.Y., Andreev S.S., Tolstykh T.N., Yatskov K.V., Karimova E.A., Makeshova A.B., Rukavitsyn O.A., Misyurin A.V., Polyakov Y.Y., Mingalimov M.A., Chudnova T.S., Gagloeva D.E., Ivanova D.D., Koneva A.I., Kochneva O.L., Zotina E.N., Grishina E.Y., Shimanovskaya L.T., Yakimets V.N., Zhelnova E.I.
Treatment outcomes for acute T-lymphoblastic leukemias/lymphomas: data from the ALL-2016 multicenter prospective randomized trial
Aleshina O.A., Galtseva I.V., Kotova E.S., Isinova G.I., Obukhova T.N., Dvirnik V.N., Sudarikov A.B., Grishunina M.E., Samoilova O.S., Kaplanov K.D., Lapin V.A., Bondarenko S.N., Fokina E.S., Minaeva N.V., Konstantinova T.S., Sveshnikova Y.V., Zinina E.E., Antipova A.S., Baranova O.Y., Borisenkova E.A., Davydova Y.O., Kapranov N.M., Kulikov S.M., Chabaeva Y.A., Troitskaya V.V., Parovichnikova E.N.
HETEROGENEITY OF CHILDHOOD B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (EGIL SUBTYPE BIV)
Demina I.A., Verzhbitskaya Т.Y., Kashpor S.A., Baidun L.V., Koniuhova T.V., Plyasunova S.A., Tsaur G.А., Rusanova E.B., Gorchakova M.V., Zueva E.E., Kazakova A.N., Zerkalenkova E.A., Olshanskaya Y.V., Abugova Y.G., Fechina L.G., Miakova N.V., Samochatova E.V., Maschan А.А., Popov А.M.
Polymorphisms of the TPMT, NUDT15 genes and 6-mercaptopurine toxicity profile in adult patients with Ph-negative acute lymphoblastic leukemia/lymphomas on the ALL-2016 protocol
Kotova E.S., Gavrilina O.A., Yakutik I.A., Sudarikov A.B., Chabaeva Y.A., Kulikov S.M., Beksaev S.G., Troitskaya V.V., Isinova G.A., Sokolov A.N., Fidarova Z.T., Lukyanova I.A., Abramova A.V., Dvirnyk V.N., Galtseva I.V., Obukhova T.N., Parovichnikova E.N.
Dasatinib: ten years of clinical practice worldwide
Abdulkadyrov K.M., Shuvaev V.A., Martynkevich I.S.
Immunophenotypic features of bone marrow tumor cell in Burkitt lymphoma/leukemia: B-lineage acute lymphoblastic leukemia diagnostics opportunities
Demina I.A., Verzhbitskaya T.Y., Kashpor S.A., Plyasunova S.A., Dubrovina M.E., Fechina L.G., Myakova N.V., Samochatova E.V., Maschan A.A., Popov A.M.
Selective glucocorticoid receptor agonists as an alternative to glucocorticoids in the treatment of acute lymphoblastic leukemia: clinical response to glucocorticoids compared with molecular effects in vitro
Vlasova O.A., Zhidkova E.M., Lylova E.S., Demko A.N., Yakubovskaya M.G., Valiev T.T., Lesovaya E.A.
Significance of immunophenotypic, cytogenetic, and molecular markers in adult patients with T-cell lymphoblastic leukemia
Vasileva A.N., Aleshina O.A., Kotova E.S., Biderman B.V., Obukhova T.N., Galtseva I.V., Dvirnyk V.N., Zakharko E.I., Sudarikov A.B., Parovichnikova E.N.
Prediction of outcome in infants acute lymphoblastic leukemia by time to achievement of molecular remission
Tsaur G.A., Nasedkina T.V., Popov A.M., Kalennik O.V., Solodovnikov A.G., Riger T.O., Yakovleva Y.A., Ivanova A.S., Druy A.E., Plekhanova O.M., Shorikov E.V., Saveliev L.I., Fechina L.G.
Venous thrombosis in children, adolescents and young adults with acute lymphoblastic leukemia receiving chemotherapy in the Republic of Belarus
Dmitriev V.V., Migal N.V., Bydanov O.I., Lipay N.V., Dmitriev E.V.
SIGNIFICANCE OF ETV6-RUNX1 FUSION GENE TRANSCRIPT DETECTION IN PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA WITH TRANSLOCATION t(12;21)(p13;q22)
Tsaur G.A., Riger Т.О., Popov A.M., Verzhbitskaya T.Y., Vakhonina L.V., Vlasova A.A., Olshanskaya Y.V., Kazakova А.N., Streneva O.V., Makarova O.V., Tsvirenko S.V., Saveliev L.I., Arakaev О.R., Fechina L.G.
Results of external quality control study in flow cytometric acute lymphoblastic leukemia diagnostics
Popov A.M., Verzhbitskaya T.U., Zueva E.E., Anan’eva O.V., Babenko E.V., Baydun L.V., Belyakova E.A., Boyakova E.V., Bortnikova O.G., Gorchakova M.V., Grivtsova L.Y., Grinkevich E.N., Davydova Y.V., Zakhar’ko E.I., Illarionova O.I., Kaprano N.M., Koroleva E.A., Kochengina S.A., Kuz’mina E.G., Kustova E.A., Makarova T.A., Mirolyubova Y.V., Murashkina O.E., Mushkarina T.Y., Nisheva E.S., Novikova I.A., Osipova E.Y., Pluzhnikova G.E., Pochtar M.E., Pronkina N.V., Rusanova E.V., Rybkina E.B., Seliverstova O.V., Tupitsin N.N., Uleyskaya G.I., Urazalieva N.T., Fechina L.G., Khoroshikh O.V., Tsareva O.E., Shchekina L.A., Plyasunova S.A., Lugovskaya S.A.
Interim results of the Ph-negative acute lymphoblastic leukemia treatment in adult patients (results of Russian research group of ALL treatment (RALL))
Parovichnikova E.N., Troitskaya V.V., Sokolov A.N., Akhmerzaeva Z.K., Kuzmina L.A., Mendeleeva L.P., Klyasova G.A., Kravchenko S.K., Gribanova Y.O., Bondarenko S.N., Baranova O.Y., Kaporskaya T.S., Ryltsova T.V., Nizamutdinova A.S., Zagoskina T.P., Zinina Y.Y., Samoylova O.S., Klimovich A.V., Karyakina Y.A., Yelufer’eva A.S., Gavrilova L.V., Konstantinova T.S., Toropova I.Y., Pristupa A.S., Vopilina N.A., Tikunova T.S., Skamorina O.P., Kaplanov K.D., Obukhova T.N., Galtseva I.V., Rusinov M.A., Kulikov S.M., Savchenko V.G.
Acute lymphoblastic leukemia with eosinophilia: diagnostic and treatment features
Gurieva O.D., Valiev T.T., Serebryakova I.N.
Flow cytometric analysis of leukemic blast cells in pediatric B-cell precursor acute lymphoblastic leukemia with translocation t(12;21)(p13;q22)/ETV6-RUNX1
Permikin Z.V., Popov A.M., Verzhbitskaya T.Y., Riger Т.О., Arakaev O.R., Vlasova A.A., Olshanskaya Y.V., Kazakova A.N., Tsvirenko S.V., Saveliev L.I., Tsaur G.A., Fechina L.G.
Visual-motor function disorders in children who survived acute lymphoblastic leukemia and central nervous system tumors
Deviaterikova A.A.
Native and pegylated forms of L-asparaginase: the assessment of effectiveness and toxicity in acute lymphoblastic leukemia treated with Berlin–Frankfurt–Munster (BFM) protocol
Shervashidze M.A., Smirnova D.S., Valiev T.T., Batmanova N.A.
Expert recommendations for pancreatitis/pancreatic necrosis treatment after L-asparaginase in children with acute lymphoblastic leukemia
Valiev T.T., Kumirova E.V., Rozinov V.M., Panferova T.R., Khvorostov I.N., Kondratchik K.L., Fuks O.Y., Kerimov P.A., Matinyan N.V., Belyaeva A.V., Efremenkov A.M., Bystrova A.A., Kurkin A.P., Gorev V.V.
Toxicity of L-asparaginase drugs in acute lymphoblastic leukemia treatment
Valiev T.T.
Hemostasis defects correction in children with acute lymphoblastic leukemia
Roshik A.S., Kolesnikova O.I., Fedorov A.V., Voloskova N.I.
Toxicity assessment of acute lymphoblastic leukemia treatment protocol ALL IC-BFM 2002
Valiev T.T., Shervashidze M.A., Belysheva T.S.
CD-19-directed immunotherapy resistance mechanisms of B-precursor acute lymphoblastic leukemia
Glukhanyuk E.V., Stepanov A.V., Popov A.M., Maschan M.A.
TOXICITY AND EFFICACY OF TYROSINE KINASE INHIBITORS IN COMBINATION WITH CHEMOTHERAPY IN PATIENT WITH RESISTANT Ph-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (CASE REPORT AND LITERATURE REVIEW)
Zarubina K.I., Parovichnikova E.N., Gavrilina O.A., Sokolov A.N., Troitskaya V.V., Kuzmina L.A., Mamonov V.E., Galstyan G.M., Savchenko V.G.
The role of high-dose methotrexate in T-cell acute lymphoblastic leukemia treatment: multicenter study results of ALL IC-BFM 2002 protocol
Valiev T.T., Shervashidze M.A., Osipova I.V., Burlutskaya T.I., Aleskerova G.A., Yuldasheva S.N., Sabantsev S.L., Paina O.V., Batmanova N.A., Zubarovskaya L.S., Kirgizov K.I., Varfolomeeva S.R.
Successful treatment of pancreatitis caused by L-asparaginase in clinical practice
Korkina Y.S., Shervashidze M.A., Valiev T.T., Batmanova N.A., Panferova T.R.
Comparative analysis of therapy results in children with acute lymphoblastic leukemia receiving ALL-MB-2002 and COALL-St.Petersburg-92 protocols
Boychenko E.G., Rumyantseva J.V., Ponomareva N.I., Livschiz M.S., Garbusova I.A., Belogurova M.B., Schaz L.I., Litvinov D.V., Lagoiko S.N., Kondratchik K.L., Tukalova N.R., Karachunsky A.I.
Pediatric acute lymphoblastic leukemia treatment protocols improvement: emphasis on minimal residual disease
Shervashidze M.A., Valiev T.T.
Detection of 11q23 (MLL) rearrangements in infant acute lymphoblastic leukemia
Tsaur G.A., Popov A.M., Aleynikova O.V., Boychenko E.G., Verzhbitskaya T.Y., Volochnik E.V., Ivanova A.S., Kalennik O.V., Kovalev S.Y., Kondtratchik K.L., Kustanovich A.M., Lapotentova E.S., Litvinov D.V., Martynkevich I.S., Myakova N.V., Nasedkina T.V., Ovsepyan V.A., Olshanskaya Y.V., Plehanova O.M., Popa A.V., Riger T.O., Savelyev L.I., Streneva O.V., Strigaleva M.V., Shmunk I.V., Shorikov E.V., Fechina L.G.
Immunophenotypic investigation of infant acute lymphoblastic leukemia
Popov A.M., Tsaur G.A., Verzhbitskaya T.Y., Streneva O.V., Shorikov E.V., Saveliev L.I., Fechina L.G.
Comparative analysis of three various chemotherapy protocols for acute lymphoblastic leukemia BFM-90m, MB-91 and PECO-92 in Moscow and St.-Petersburg
Boichenko E.G., Petrova E.M., Ivanovskaya M.B., Garbusova I.A., Belogurova M.B., Radulesku G.G., Roumiantseva Y.V., Litvinov D.V., Lagoiko S.N., Kondratchik K.L., Ponomareva N.I., Tukalova N.R., Karachunsky A.I.
CDKN2A/p16INK4a DELETION IS NOT A POOR PROGNOSTIC FACTOR IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS TREATED ACCORDING TO PROTOCOL RALL-2009
Piskunova I.S., Obukhova T.N., Parovichnikova E.N., Kulikov S.M., Gavrilina O.A., Lukyanova I.A., Savchenko V.G.
Comparative efficacy of acute lymphoblastic leukemia treatment of children in St.-Petersburg using two COALL-92 versions
Boychenko E.G., Petrova E.M., Garbuzova I.A., Nikitina E.A., Shchugareva L.M., Kulakova T.N., Makarova T.A., Belogurova M.B., Radulesku G.G., Viktorovich T.D., Chavpetsova E.D., Shats L.I., Uleyskaya G.I., Martynkevich I.S., Zueva E.E.
COVID-19 in patients with acute lymphoblastic leukemia
Chudnova T. ., Misyurina E.N., Baryakh E.A., Tolstykh T.N., Shimanovskaya L.T., Gagloeva D.E., Zhelnova E.I., Makeshova A.B., Yatskov K.V., Zotina E.N., Ivanova D.D., Mingalimov M.A., Kochneva O.L., Grishina E.Y., Yakimets V.N.
Pharmacoeconomic analysis of treatment of children with acute lymphoblastic leukemia according to ALL-MB-2002 protocol
Miga N.V., Shmargun A.S., Aleinikova O.V.
Allogeneic hematopoietic stem cells transplantation with reduced intensity conditioning regimen in children and adolescents with unfavorable forms of acute lymphoblastic leukemia
Semenova E.V., Stancheva N.V., Alyanskiy A.L., Babenko E.V., Vavilov V.N., Morozova E.V., Bondarenko S.N., Sipol A.A., Paina O.V., Slesarchuk O.A., Barkhatov I.M., Zubarovskaya L.S., Afanasiev B.V.
Clinical and pharmacogenetics factors as therapeutic predictors in pediatric acute lymphoblastic leukemia
Gurieva O.D., Valiev T.T., Savelyeva M.I., Varfolomeeva S.R.
Complex rehabilitation of children with long-term acute lymphoblastic leukemia remission
Tkachenko I.V., Teslenko B.V., Rumyantsev A.G.
Prognostic factors of children’s acute lymphoblastic leukemia therapy in Moscow—Berlin protocols
Roumiantseva J.V., Karachunsky A.I., Aleinikova O.V., Fechina L.G., Schamardina A.V., Litvinov D.V., Ponomareva N.I., Boichenko E.G., Sidorenko L.V., Dudkin S.A., Streneva O.V., Kondratchik K.L., Mansurova E.G., Minkina L.M., Lapotentova E.S., Inuschkina E.V., Yudina N.B., Pavlova G.P., Zhukovskaya E.V., Chlebnikova O.P., Lagoiko S.N., Bascharova E.V., Denisov R.E., Zlobina V.D., Banschikova E.S., Aslanyan K.S., Kondakova E.V., Celousova E.V., Myakova N.V., Turobova T.V., Riskal O.V., Chipsanova N.F., Varfolomeeva S.R., Rumiantsev A.G.
Molecular genetic abnormalities in patients with T-cell acute lymphoblastic leukemia: a literature review
Vasileva A.N., Aleshina O.A., Biderman B.V., Sudarikov A.B.
RUSSIAN-BELARUSIAN MULTICENTER GROUP STANDARD GUIDELINES FOR CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA FLOW CYTOMETRIC DIAGNOSTICS
Novikova I.A., Verzhbitskaya T.Y., Movchan L.V., Tsaur G.A., Belevtsev М.V., Popov A.M.
Flow cytometric minimal residual disease monitoring in children with acute lymphoblastic leukemia treated by regimens with reduced intensity
Popov A.M., Verzhbitskaya Y.Y., Tsaur G.A., Solodovnikov A.G., Arakaev O.R., Streneva O.V., Khlebnikova O.P., Shorikov E.V., Saveliev L.I., Lagoyko S.N., Rumyantseva Y.V., Karachunskiy A.I., Fechina L.G.
Optimization of native E. coli-asparaginase therapy in standard risk-group children with acute lymphoblastic leukemia treated by the ALL-MB 2002 protocol
Goroshkova M.Y., Rumyantseva Y.V., Aleinikova O.V., Dudkin S.A., Fechina L.G., Shamardina A.V., Streneva O.V., Kondratchik K.L., Minkina L.M., Lapotentova E.S., Inyushkina E.V., Kozlova O.B., Zhukovskaya E.V., Khlebnikova O.P., Basharova E.V., Timofeeva V.N., Pavlova G.P., Zlobina V.D., Utrobina O.A., Banshchikova E.S., Aslanyan K.S., Kondakova E.V., Tselousova E.V., Myakova N.V., Turobova T.V., Ryskal O.V., Fuks O.Y., Lebedev V.V., Chipsanova N.F., Varfolomeeva S.R., Karachunsky A.I.
First experience of total body irradiation in conditioning regimes for allogenic hematopoietic stem cells transplantation in children with acute lymphoblastic leukemia in Saint Petersburg
Dinikina Y.V., Mikhailov A.V., Rusina M.A., Smirnova A.Y., Vorob’ov N.A., Kataev N.A., Kubasov A.V.
Obesity in children with acute lymphoblastic leukemia in remission: the evaluation of causes, hidden nutritional deficiency and the experience of its correction by using artificial enteral nutrition
Vashura A.Y., Zhukovskaya E.V., Lukina S.S., Gavrilova A.E.
IKZF1 DELETIONS ARE INDEPENDENT PROGNOSTIC FACTOR IN PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
Tsaur G.A., Druy A.Е., Solodonikov A.G., Popov A.M., Shapochnik A.P., Vakhonina L.V., Vlasova А.А., Riger Т.О., Verzhbitskaya T.Y., Olshanskaya Y.V., Shorikov E.V., Arakaev О.R., Saveliev L.I., Fechina L.G.
Leukemia-associated immunophenotype of tumor cells in childhood B-precursors acute lymphoblastic leukemia
Movchan L.V.
1 - 53 of 53 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

The website of the journal Oncohematology contains materials intended exclusively for healthcare professionals.

By closing this message, you confirm* that you are a licensed healthcare professional or a student of a medical educational institution.

This one-time confirmation is valid for the next 30 days.